Philips sues Boston Scientific over cardiac diagnostic patents
03-11-2020
Lab instrument maker accuses rival of stealing trade secrets
02-11-2020
Pavel Kapysh / Shutterstock.com
The US Court of Appeals for the Federal Circuit has cancelled a lower court ruling holding that a Bard patent for a vascular access device was both not infringed and patent-ineligible.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Bard, Federal Circuit, AngioDynamics, vascular access port, Delaware, district court, patent, infringement
